Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Applied Genetic Technologies follow-on offering
We advised the underwriters on the equity offering
Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering
Dream Finders Homes $143.5 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Perion Network $66 million follow-on offering
We advised Perion, whose shares are listed on Nasdaq and the Tel Aviv Stock Exchange
Energizer Holdings $650 million incremental financing
We advised the joint lead arrangers and bookrunners on the incremental term facility
Generation Bio $225.4 million stock offering
We advised the underwriters on the public equity offering
Gracell Biotechnologies $209 million IPO and Nasdaq listing
We advised the underwriters on the IPO of ADSs
Energizer Holdings $950 million refinancing
Davis Polk advised (i) the joint lead arrangers and joint bookrunners and (ii) the administrative agent, in connection with a $550 million senior secured term loan facility and a $400…